Vycor Medical (VYCO) Income from Continuing Operations (2010 - 2026)
Vycor Medical (VYCO) reported Income from Continuing Operations of 20095.0 for Q1 2026, up 152.18% year-over-year from 7968.65 in Q1 2025, and up 213.22% quarter-over-quarter from 17749.0 in Q4 2025.
Vycor Medical (VYCO) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Income from Continuing Operations data on file, last reported at 20095.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 20095.0, up 152.18% year-over-year; the trailing twelve-month figure through Mar 2026 was 33049.0 (up 199.77% YoY), and the FY2025 annual result was 25560.0, down 1.76% from the prior year.
- Income from Continuing Operations advanced to 20095.0 in Q1 2026 per VYCO's latest filing, from 17749.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 75149.0 in Q4 2024 and troughed at 112312.0 in Q3 2022.
- A 5-year average of 26821.41 and a median of 30507.0 in 2024 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations slumped 10463.31% in 2022, then surged 357.41% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 98718.0 in 2022, then grew by 29.38% to 69710.0 in 2023, then surged by 207.8% to 75149.0 in 2024, then sank by 123.62% to 17749.0 in 2025, then soared by 213.22% to 20095.0 in 2026.
- Business Quant data shows VYCO's Income from Continuing Operations at 20095.0 in Q1 2026, 17749.0 in Q4 2025, and 4990.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 | 20,095.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,095.00 |
| Dec 31, 2025 | -17,749.00 |
| Sep 30, 2025 | 4,990.00 |
| Jun 30, 2025 | 25,713.00 |
| Mar 31, 2025 | -38,514.00 |
| Dec 31, 2024 | 75,149.00 |
| Sep 30, 2024 | -59,770.00 |
| Jun 30, 2024 | -9,989.00 |
| Mar 31, 2024 | -30,507.00 |
| Dec 31, 2023 | -69,710.00 |
| Sep 30, 2023 | -51,479.00 |
| Jun 30, 2023 | 70,791.00 |
| Mar 31, 2023 | 7,569.00 |
| Dec 31, 2022 | -98,718.00 |
| Sep 30, 2022 | -112,312.00 |
| Jun 30, 2022 | -97,726.00 |
| Mar 31, 2022 | -73,797.00 |
| Dec 31, 2021 | 185,019.00 |
| Sep 30, 2021 | 7,659.00 |
| Jun 30, 2021 | 943.00 |